Authorea (Authorea),
Journal Year:
2024,
Volume and Issue:
unknown
Published: March 13, 2024
Obesity
has
been
identified
as
an
independent
risk
factor
for
severe
outcomes
in
humans
with
coronavirus
disease
2019
(COVID-19)
and
other
infectious
diseases.
Here,
we
established
a
mouse
model
of
COVID-19
using
the
murine
betacoronavirus,
hepatitis
virus
1
(MHV-1).
C57BL/6
C3H/HeJ
mice
exposed
to
MHV-1
developed
mild
disease,
respectively.
Obese
clinical
manifestations
similar
those
lean
controls.
In
contrast,
all
obese
succumbed
by
8
days
post-infection,
compared
50%
mortality
rate
Notably,
both
lung
lesions
consistent
human
COVID-19,
marked
evidence
diffuse
alveolar
damage
(DAD).
To
identify
early
predictive
biomarkers
worsened
mice,
sequenced
RNA
from
whole
blood
2
post-infection
assessed
changes
gene
pathway
expression.
Many
pathways
uniquely
altered
aligned
found
COVID-19.
Furthermore,
observed
expression
related
unfolded
protein
response
lipid
metabolism
infected
their
counterparts,
suggesting
role
severity
outcomes.
This
study
presents
novel
studying
elucidating
mechanisms
underlying
hosts.
Virology Journal,
Journal Year:
2023,
Volume and Issue:
20(1)
Published: Aug. 2, 2023
Abstract
Coronavirus
disease
2019
(COVID-19)
is
an
acute
respiratory
caused
by
severe
syndrome
coronavirus
2
(SARS-CoV-2),
which
can
lead
to
distress
(ARDS),
multi-organ
failure
and
death,
posing
significant
threat
human
health.
Studies
have
found
that
pathological
mechanisms,
such
as
cytokine
storms
uncontrolled
innate
immune
system
activation,
release
of
damage-associated
molecular
patterns
during
tissue
injury
a
high
incidence
thrombotic
events,
are
associated
with
the
function
dysfunction
neutrophils.
Specifically,
increased
formation
low-density
neutrophils
(LDNs)
neutrophil
extracellular
traps
(NETs)
has
been
shown
be
closely
linked
severity
poor
prognosis
in
patients
COVID-19.
Our
work
focuses
on
understanding
number,
abnormal
lung
infiltration,
elevated
neutrophil-to-lymphocyte
ratio
pathogenesis
We
also
explore
involvement
NETs
LDNs
progression
thrombosis
formation,
along
potential
therapeutic
strategies
targeting
formation.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 16, 2022
COVID-19
patients
have
a
high
incidence
of
thrombosis,
and
thromboembolic
complications
are
associated
with
severe
mortality.
disease
is
hyper-inflammatory
response
(cytokine
storm)
mediated
by
the
immune
system.
However,
role
inflammatory
in
thrombosis
remains
incompletely
understood.
In
this
review,
we
investigate
crosstalk
between
inflammation
context
COVID-19,
focusing
on
contributions
to
pathogenesis
propose
combined
use
anti-inflammatory
anticoagulant
therapeutics.
Under
conditions,
interactions
neutrophils
platelets,
platelet
activation,
monocyte
tissue
factor
expression,
microparticle
release,
phosphatidylserine
(PS)
externalization
as
well
complement
activation
collectively
involved
immune-thrombosis.
Inflammation
results
apoptosis
blood
cells,
leading
release
PS
cells
microparticles,
which
significantly
enhances
catalytic
efficiency
tenase
prothrombinase
complexes,
promotes
thrombin-mediated
fibrin
generation
local
clot
formation.
Given
risk
importance
antithrombotic
therapies
has
been
generally
recognized,
but
certain
deficiencies
treatment
gaps
remain.
Antiplatelet
drugs
not
combination
treatments,
thus
fail
dampen
procoagulant
activity.
Current
treatments
also
do
an
optimal
time
for
anticoagulation.
The
efficacy
depends
therapy
initiation.
best
early
possible
after
diagnosis,
ideally
stage
disease.
We
elaborate
mechanisms
long
COVID
complications,
including
persistent
inflammation,
endothelial
injury
dysfunction,
coagulation
abnormalities.
above-mentioned
contents
provide
therapeutic
strategies
further
improve
patient
outcomes.
Diagnostics,
Journal Year:
2022,
Volume and Issue:
12(9), P. 2147 - 2147
Published: Sept. 3, 2022
Body
fluids
are
constantly
replenished
with
a
population
of
genetically
diverse
cell-free
DNA
(cfDNA)
fragments,
representing
vast
reservoir
information
reflecting
real-time
changes
in
the
host
and
metagenome.
As
many
body
can
be
collected
non-invasively
one-off
serial
fashion,
this
tapped
to
develop
assays
for
diagnosis,
prognosis,
monitoring
wide-ranging
pathologies,
such
as
solid
tumors,
fetal
genetic
abnormalities,
rejected
organ
transplants,
infections,
potentially
others.
The
translation
cfDNA
research
into
useful
clinical
tests
is
gaining
momentum,
recent
progress
being
driven
by
rapidly
evolving
preanalytical
analytical
procedures,
integrated
bioinformatics,
machine
learning
algorithms.
Yet,
despite
these
spectacular
advances,
remains
very
challenging
analyte
due
its
immense
heterogeneity
fluctuation
vivo.
It
increasingly
recognized
that
high-fidelity
reconstruction
stored
cfDNA,
turn
development
fit
roll-out,
requires
much
deeper
understanding
both
physico-chemical
features
biological,
physiological,
lifestyle,
environmental
factors
modulate
it.
This
daunting
task,
but
significant
upsides.
In
review
we
showed
how
expanded
knowledge
on
biology
faithful
reverse-engineering
samples
promises
(i)
augment
sensitivity
specificity
existing
assays;
(ii)
expand
repertoire
disease-specific
markers,
thereby
leading
powerful
(iii)
reshape
personal
molecular
medicine;
(iv)
have
an
unprecedented
impact
genetics
research.
Cell Reports Medicine,
Journal Year:
2022,
Volume and Issue:
3(12), P. 100848 - 100848
Published: Nov. 21, 2022
Multisystem
inflammatory
syndrome
in
children
(MIS-C)
is
a
delayed-onset,
COVID-19-related
hyperinflammatory
illness
characterized
by
severe
acute
respiratory
coronavirus
2
(SARS-CoV-2)
antigenemia,
cytokine
storm,
and
immune
dysregulation.
In
COVID-19,
neutrophil
activation
central
to
complications,
yet
the
role
of
neutrophils
MIS-C
undefined.
Here,
we
collect
blood
from
152
children:
31
cases
MIS-C,
43
pediatric
78
controls.
We
find
that
display
granulocytic
myeloid-derived
suppressor
cell
(G-MDSC)
signature
with
highly
altered
metabolism
distinct
interferon-stimulated
gene
(ISG)
response
observe
COVID-19.
Moreover,
extensive
spontaneous
extracellular
trap
(NET)
formation
identify
degranulation
signatures.
Mechanistically,
determine
SARS-CoV-2
complexes
are
sufficient
trigger
NETosis.
Our
findings
suggest
presentation
during
could
be
mechanistically
linked
persistent
driven
uncontrolled
NET
release
vasculature.
International Journal of Nanomedicine,
Journal Year:
2023,
Volume and Issue:
Volume 18, P. 5265 - 5287
Published: Sept. 1, 2023
Abstract:
Neutrophil
extracellular
traps
(NETs)
are
large
DNA
reticular
structures
secreted
by
neutrophils
and
decorated
with
histones
antimicrobial
proteins.
As
a
key
mechanism
for
to
resist
microbial
invasion,
NETs
play
an
important
role
in
the
killing
of
microorganisms
(bacteria,
fungi,
viruses).
Although
mostly
known
mediating
killing,
increasing
evidence
suggests
that
excessive
induced
stimulation
physical
chemical
components,
microorganisms,
pathological
factors
can
exacerbate
inflammation
organ
damage.
This
review
summarizes
induction
focuses
on
strategies
inhibiting
NETosis
mechanisms
involved
pathogen
evasion
NETs.
Furthermore,
herbal
medicine
inhibitors
nanodelivery
improve
efficiency
inhibition
levels
Graphical
Keywords:
neutrophil
traps,
inflammation,
targeted
inhibition,
nanotherapy,
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Dec. 5, 2024
Abstract
Neutrophils,
the
most
abundant
type
of
granulocyte,
are
widely
recognized
as
one
pivotal
contributors
to
acute
inflammatory
response.
Initially,
neutrophils
were
considered
mobile
infantry
innate
immune
system,
tasked
with
immediate
response
invading
pathogens.
However,
recent
studies
have
demonstrated
that
versatile
cells,
capable
regulating
various
biological
processes
and
impacting
both
human
health
disease.
Cytokines
other
active
mediators
regulate
functional
activity
by
activating
multiple
receptors
on
these
thereby
initiating
downstream
signal
transduction
pathways.
Dysfunctions
in
disruptions
neutrophil
homeostasis
been
implicated
pathogenesis
numerous
diseases,
including
cancer
disorders,
often
due
aberrant
intracellular
signaling.
This
review
provides
a
comprehensive
synthesis
functions,
integrating
advancements
this
field.
Moreover,
it
examines
roles
signaling
pathways
involved
regulation
activity.
The
pathophysiology
diseases
emerging
therapeutic
approaches
targeting
them
also
elaborated.
addresses
current
limitations
within
field
research,
highlighting
critical
gaps
knowledge
warrant
further
investigation.
In
summary,
seeks
establish
multidimensional
model
regulation,
providing
new
perspectives
for
potential
clinical
applications
research.
Frontiers in Nutrition,
Journal Year:
2022,
Volume and Issue:
9
Published: Oct. 20, 2022
Short-chain
fatty
acids
(SCFAs)
are
metabolites
released
by
bacterial
components
of
the
microbiota.
These
molecules
have
a
wide
range
effects
in
microbiota
itself,
but
also
host
cells
which
they
known
for
contributing
to
regulation
cell
metabolism,
barrier
function,
and
immunological
responses.
Recent
studies
indicate
that
these
important
players
gut-lung
axis
highlight
possibility
using
strategies
alter
their
intestinal
production
prevent
or
treat
distinct
lung
inflammatory
diseases.
Here,
we
review
SCFA
butyrate
its
derivatives
vitro
vivo
on
murine
models
respiratory
disorders,
besides
discussing
potential
therapeutic
use
other
SCFAs
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(3), P. 929 - 929
Published: March 16, 2023
COVID-19,
the
infectious
disease
caused
by
severe
acute
respiratory
syndrome
coronavirus-2
(SARS-CoV-2),
is
frequently
associated
with
pulmonary
thrombotic
events,
especially
in
hospitalized
patients.
Severe
SARS-CoV-2
infection
characterized
a
proinflammatory
state
and
an
disbalance
hemostasis.
Immune
pathology
analysis
supports
inflammatory
nature
of
arterial
thrombi
composed
white
blood
cells,
neutrophils,
CD3+
CD20+
lymphocytes,
fibrin,
red
platelets.
cytokines,
chemokines,
complement
system
are
key
drivers
immunothrombosis,
as
they
induce
damage
endothelial
cells
initiate
procoagulant
positive
feedback
loops.
Neutrophil
extracellular
traps
induced
COVID-19-associated
“cytokine
storm”,
platelets,
coagulation
pathways
close
inflammation–endotheliopathy–thrombosis
axis,
contributing
to
SARS-CoV-2-associated
events.
The
hypothesis
immunothrombosis
also
supported
minor
role
venous
thromboembolism
chest
CT
imaging
data
showing
peripheral
clots
lesions
high
incidence
events
despite
routine
thromboprophylaxis.
Understanding
complex
mechanisms
behind
COVID-19-induced
thrombosis
will
lead
future
combination
therapies
for
patients
that
would
target
crossroads
pathways.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Feb. 26, 2024
Background
Pre-neutrophils,
while
developing
in
the
bone
marrow,
transcribe
Inhba
gene
and
synthesize
Activin-A
protein,
which
they
store
release
at
earliest
stage
of
their
activation
periphery.
However,
role
neutrophil-derived
is
not
completely
understood.
Methods
To
address
this
issue,
we
developed
a
neutrophil-specific
Activin-A-deficient
animal
model
(
S100a8-Cre/Inhba
fl/fl
mice)
analyzed
immune
response
to
Influenza
A
virus
(IAV)
infection.
More
specifically,
evaluation
body
weight
lung
mechanics,
molecular
cellular
analyses
bronchoalveolar
lavage
fluids,
flow
cytometry
cell
sorting
cells,
as
well
histopathological
analysis
tissues,
were
performed
PBS-treated
IAV-infected
transgenic
animals.
Results
We
found
that
deficiency
led
exacerbated
pulmonary
inflammation
widespread
hemorrhagic
histopathology
lungs
animals
was
associated
with
an
exuberant
production
neutrophil
extracellular
traps
(NETs).
Moreover,
deletion
receptor
ALK4/ACVR1B
neutrophils
IAV-induced
pathology
well,
suggesting
themselves
are
potential
targets
Activin-A-mediated
signaling.
The
pro-NETotic
tendency
further
verified
context
thioglycollate-induced
peritonitis,
characterized
by
robust
peritoneal
neutrophilia.
Of
importance,
transcriptome
revealed
alterations
consistent
predisposition
for
NET
release.
Conclusion
Collectively,
our
data
demonstrate
Activin-A,
secreted
upon
periphery,
acts
feedback
mechanism
moderate
limit
collateral
tissue
damage
caused
excess
during
inflammatory
response.